Attached files

file filename
8-K - 8-K - IMAX CORPd503867d8k.htm

IMAX CORPORATION

Exhibit 99.1

 

LOGO

IMAX CORPORATION

2525 Speakman Drive

Mississauga, Ontario, Canada L5K 1B1

Tel: (905) 403-6500 Fax: (905) 403-6450

www.imax.com

IMAX CORPORATION REPORTS SECOND QUARTER 2018 RESULTS

HIGHLIGHTS

 

    Strong financial results driven by compelling blockbuster content worldwide, global network expansion and ongoing cost discipline – three factors the Company anticipates will continue to drive earnings in the future.

 

    Delivered Q2 2018 earnings per share and adjusted earnings per share of $0.12 and $0.30, respectively compared to a loss per share of $0.03 and adjusted earnings per share of $0.15, respectively in Q2 2017.

 

    Studios’ continued emphasis on blockbuster content, coupled with consumers’ desire to experience that content in differentiated ways, drove IMAX global box office to $343 million in the second quarter, a 28% increase compared to Q2 2017 and, representing the Company’s fifth consecutive period of quarterly box office growth.

 

    Repurchased $33.0 million of shares in the second quarter at an average price of $22.01 per share, and repurchased $46 million of shares in the first half of 2018 at an average price of $21.54 per share.

NEW YORK – July 25, 2018 – IMAX Corporation (NYSE:IMAX) today reported second quarter 2018 revenues of $98.3 million, gross profit of $60.4 million and net income attributable to common shareholders of $7.6 million, which calculates to $0.12 per diluted share. Adjusted net income attributable to common shareholders for the second quarter was $19.0 million, which calculates to $0.30 per diluted share. Adjusted EBITDA per Credit Facility was $39.5 million. For reconciliations of reported results to non-GAAP financial results, and for the definition and reconciliation of Adjusted EBITDA per Credit Facility, please see the end of this press release.

“Building on our first quarter momentum, we continued to demonstrate the value of our differentiated consumer experience, expanding global footprint and focus on blockbuster content from around the world. These factors, coupled with our continued focus on controlling costs, helped drive second quarter adjusted EBITDA of $39.5 million, a 35% increase compared to the second quarter last year. Through the first six months of 2018, adjusted EBITDA is up 49% compared to the same period last year,” said IMAX CEO Richard L. Gelfond. “Not only are studios emphasizing blockbuster-type content, consumers are increasingly seeking differentiated ways to experience that content. We believe IMAX is uniquely positioned to benefit from these trends, especially with the roll out of our new IMAX® with Laser experience, which we expect will further increase the differentiation of The IMAX Experience®.”

Second Quarter 2018 Results

Network Update

During the quarter, the Company installed 31 theater systems, 30 of which were for new theater locations. The total IMAX® theater network consisted of 1,410 systems as of June 30, 2018, of which 1,314 were in commercial multiplexes. There were 635 theaters in backlog as of June 30, 2018, compared to the 580 in backlog as of June 30, 2017.

IMAX also signed contracts for 40 new theaters and 98 upgrades in the second quarter of 2018. For a breakdown of theater system signings, installations, network and backlog by type for the second quarter of 2018, please see the end of this press release.

 


Box Office Update

Gross box office from IMAX DMR® films increased 27.4% to $342.6 million in the second quarter of 2018 from $268.9 million in the second quarter of 2017. Gross box office was generated primarily by the exhibition of 14 films (10 new and 4 carryovers), as compared to 16 films (11 new and 5 carryovers) exhibited in the second quarter of 2017.

Second Quarter Consolidated Results

The gross margin across all segments in the second quarter of 2018 was $60.4 million, or 61.4% of total revenues, compared to $49.5 million, or 56.4% of total revenues, in the second quarter of 2017. Operating expenses (which includes SG&A, excluding stock-based compensation, plus R&D) were $30.3 million in the quarter.

Gelfond continued, “Blockbuster content from Hollywood, China, India and South Korea will hit IMAX screens across the globe this year. Expanding our content offering by including more local-language titles is a key initiative of the Company, given our 1,300-plus screens span nearly 80 countries. We believe that tailoring our slate to the varying consumer preferences in diverse markets such as China will increase the box office productivity of our network. In addition to the compelling mix of global blockbusters, we are also confident that the launch of our new global brand campaign will more effectively communicate to consumers the benefits of the premium IMAX experience. We expect the new brand campaign, combined with the launch of IMAX with Laser and our growing global footprint, to drive incremental attendance at IMAX screens around the world.”

Second Quarter Segment Results

Network Business

 

    Network business revenues were $60.9 million in the quarter, compared with $47.4 million in the prior-year period. Gross margin for the network business were 70.5% in the most recent quarter, compared to 66.3% in the prior-year period. The increase in revenue and gross margin was primarily driven by a 27.4% increase in box office.

 

    IMAX DMR revenues were $36.2 million in the second quarter of 2018, compared to $27.8 million in the second quarter of 2017. Gross margin for the IMAX DMR segment was 67.1%, compared to 61.2% in the prior-year comparative period.

 

    Revenue from joint revenue-sharing arrangements were $24.7 million in the quarter, compared with $18.9 million in the prior-year period. Gross margin for joint revenue-sharing arrangements was 75.3%, compared to 72.3% in the prior-year comparative period.

Theater Business

 

    Theater business segment revenues were $30.9 million in the quarter, compared with $32.7 million in the prior-year period, primarily reflecting the installation of 3 fewer sales-type theaters.

 

    Gross margin on sales and sales-type leases was 57.6% compared with 60.3% in the year-ago period. The decrease in the recent period is primarily the result of three fewer system installations compared to the prior year period.

Supplemental Materials

For more information about the Company’s results, please refer to the IMAX Investor Relations website located at investors.imax.com.

Investor Relations Website and Social Media

On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at www.imax.com/content/investor-relations. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag. In addition, the Company maintains a Twitter account: @IMAX_Investors. The Company intends to use Twitter to disclose the box office information, as well as other information that may be of interest to the Company’s investor community.

 

2


The information posted on the Company’s website and/or via its Twitter account may be deemed material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company’s website and its Twitter account in addition to the Company’s press releases, SEC filings and public conference calls and webcasts.

Conference Call

The Company will host a conference call today at 4:30PM ET to discuss its second quarter 2018 financial results. This call is being webcast by Nasdaq and can be accessed at investors.imax.com. To access the call via telephone, interested parties in the US and Canada should dial (800) 263-0877 approximately 5 to 10 minutes before the call begins. Other international callers should dial (438) 968-3557. The conference ID for the call is 5362019. A replay of the call will be available via webcast at investors.imax.com or via telephone by dialing (888) 203-1112 (US and Canada), or (647) 436-0148 (international). The Conference ID for the telephone replay is 5362019.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of June 30, 2018, there were 1,410 IMAX theater systems (1,314 commercial multiplexes, 12 commercial destinations, 84 institutional) operating in 79 countries. On Oct. 8, 2015, shares of IMAX China, a subsidiary of IMAX Corp., began trading on the Hong Kong Stock Exchange under the stock code “HK.1970.”

IMAX®, IMAX® 3D, IMAX DMR®, Experience It In IMAX®, An IMAX 3D Experience®, The IMAX Experience®, IMAX Is Believing® and IMAX nXos® are trademarks of IMAX Corporation. More information about the Company can be found at www.imax.com. You may also connect with IMAX on Facebook (www.facebook.com/imax), Twitter (www.twitter.com/imax) and YouTube (www.youtube.com/imaxmovies).

###

This press release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. Important factors that could affect these statements include, but are not limited to, references to future capital expenditures (including the amount and nature thereof), business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the “Company”) and expectations regarding the Company’s future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada; risks related to the Company’s growth and operations in China; the performance of IMAX DMR films; the signing of theater system agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates; competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to recent consolidation among commercial exhibitors and studios; risks related to new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security; risks related to the Company’s inability to protect the Company’s intellectual property; general economic, market or business conditions; the failure to convert theater system backlog into revenue; changes in laws or regulations; the failure to fully realize the projected cost savings and benefits from the Company’s restructuring initiative; and other factors, many of which are beyond the control of the Company. These factors, other risks and uncertainties and financial details are discussed in IMAX’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

 

3


For additional information please contact:

 

   

Investors:

IMAX Corporation, New York

Michael K. Mougias

212-821-0187

mmougias@imax.com

 

  

Media:

IMAX Corporation, New York

Amanda Collins

212-821-0155

abcollins@imax.com

 

4


Additional Information

Signings and Installations

 

 

 

 

June 30, 2018

     Three Months
Ended June 30,
 
Theater Signings:    2018     2017  

Full new sales and sales-type lease arrangements

     9       14  

New traditional joint revenue sharing arrangements

     31       31  

New hybrid joint revenue sharing lease arrangements

     —         47  
  

 

 

   

 

 

 

Total new theaters

     40       92  

Upgrades of IMAX theater systems

     98       3  
  

 

 

   

 

 

 

Total Theater Signings

     138       95  
  

 

 

   

 

 

 
     Three Months
Ended June 30,
 
Theater Installations:    2018     2017  

Full new sales and sales-type lease arrangements

     9       12  

New traditional joint revenue sharing arrangements

     19       18  

New hybrid joint revenue sharing lease arrangements

     2       3  
  

 

 

   

 

 

 

Total new theaters

     30       33  

Upgrades of IMAX theater systems

     1 (1)      1 (1) 
  

 

 

   

 

 

 

Total Theater Installations

     31       34  
  

 

 

   

 

 

 
     Three Months
Ended June 30,
 
Theater Backlog:    2018     2017  

New sales and sales-type lease arrangements

     181 (2)      174  

New joint revenue sharing arrangements

    

Hybrid lease arrangements

     115       137  

Traditional arrangements

     339       269  
  

 

 

   

 

 

 

Total Theater Backlog

     635 (3)      580 (4) 
  

 

 

   

 

 

 
     Three Months
Ended June 30,
 
Theater Network:    2018     2017  

Commercial Multiplex Theaters:

    

Sales and sales-type lease arrangements

     576 (5)      483  

Traditional joint revenue sharing arrangements

     628       554  

Hybrid joint revenue sharing lease arrangements

     110       117  
  

 

 

   

 

 

 

Total Commercial Multiplex Theaters

     1,314       1,154  

Commercial Destination Theaters

     12       13  

Institutional Theaters

     84       90  
  

 

 

   

 

 

 

Total Theater Network

     1,410       1,257  
  

 

 

   

 

 

 

 

(1) Includes one installation of an upgrade to a laser-based digital system under a joint revenue (2017 – one under a sales arrangement).
(2) Includes 22 hybrid sales theater systems which were previously classified under joint revenue sharing arrangements – hybrid sales arrangements.
(3) Includes 75 new laser projection system configurations, including 101 upgrades of existing locations to laser projection system configurations (99 of these 101 are for the new next generation laser projection system configurations).
(4) Includes 24 laser projection system configurations and four upgrades of existing locations to laser projection system configurations.
(5) Includes 35 theater systems which were previously classified under joint revenue sharing arrangements – hybrid sales arrangements. See “Critical Accounting Policies and estimates” in the form 10-Q for further details of the adoption impact of ASC Topic 606 on the Company’s revenues.

 

5


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of U.S. dollars, except per share amounts)

(Unaudited)

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2018     2017     2018     2017  

Revenues

        

Equipment and product sales

   $ 15,368     $ 21,334     $ 34,881     $ 32,879  

Services

     54,785       44,603       99,531       83,447  

Rentals

     25,124       19,438       43,326       35,294  

Finance income

     3,068       2,383       5,591       4,794  
  

 

 

   

 

 

   

 

 

   

 

 

 
     98,345       87,758       183,329       156,414  
  

 

 

   

 

 

   

 

 

   

 

 

 

Costs and expenses applicable to revenues

        

Equipment and product sales

     7,549       11,453       15,521       18,917  

Services

     23,633       21,266       43,984       41,080  

Rentals

     6,759       5,580       12,728       11,187  
  

 

 

   

 

 

   

 

 

   

 

 

 
     37,941       38,299       72,233       71,184  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

     60,404       49,459       111,096       85,230  

Selling, general and administrative expenses

     32,608       28,589       60,691       59,531  

(including share-based compensation expense of $6.2 million and $10.7 million for the three and six months ended June 30, 2018 (2017 — $6.2 million and $11.0 million, respectively))

        

Research and development

     3,922       5,678       7,514       10,012  

Asset impairments

     —         1,225       —         1,225  

Amortization of intangibles

     965       779       1,857       1,380  

Receivable provisions, net of recoveries

     355       940       806       1,125  

Legal arbitration award

     7,500       —         7,500       —    

Exit costs, restructuring charges and associated impairments

     456       10,258       1,158       10,258  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

     14,598       1,990       31,570       1,699  

Interest income

     243       280       490       508  

Interest expense

     (851     (435     (1,345     (890
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations before income taxes

     13,990       1,835       30,715       1,317  
  

 

 

   

 

 

   

 

 

   

 

 

 

(Provision for) recovery of income taxes

     (3,635     238       (8,088     124  

Loss from equity-accounted investments, net of tax

     (100     (264     (305     (519
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     10,255       1,809       22,322       922  

Less: income loss attributable to non-controlling interests

     (2,630     (3,521     (6,192     (2,559
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) attributable to common shareholders

   $ 7,625     $ (1,712   $ 16,130     $ (1,637
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per share attributable to common shareholders – basic and diluted:

 

     

Net income (loss) per share — basic and diluted

   $ 0.12       (0.03   $ 0.25     $ (0.02
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of shares outstanding (000’s):

        

Basic

     63,314       65,793       63,931       66,076  

Fully Diluted

     63,426       65,992       64,006       66,548  

Additional Disclosure:

        

Depreciation and amortization(1)

   $ 14,513     $ 13,266     $ 28,034     $ 25,354  

 

(1) Includes $0.4 million and $0.5 million of amortization of deferred financing costs charged to interest expense for the three and six months ended June 30, 2018, respectively (2017 – $0.2 million and $0.3 million, respectively).

 

6


IMAX CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of U.S. dollars)

(Unaudited)

 

     June 30,
2018
    December 31,
2017
 

Assets

    

Cash and cash equivalents

   $ 133,042     $ 158,725  

Accounts receivable, net of allowance for doubtful accounts of $2,348 (December 31, 2017 — $1,613)

     113,461       130,546  

Financing receivables

     125,756       129,494  

Inventories

     40,705       30,788  

Prepaid expenses

     9,401       7,549  

Film assets

     15,193       5,026  

Property, plant and equipment

     276,129       276,781  

Other assets

     61,956       26,757  

Deferred income taxes

     24,386       30,708  

Other intangible assets

     30,456       31,211  

Goodwill

     39,027       39,027  
  

 

 

   

 

 

 

Total assets

   $ 869,512     $ 866,612  
  

 

 

   

 

 

 

Liabilities

    

Bank indebtedness

   $ 24,377     $ 25,357  

Accounts payable

     15,027       24,235  

Accrued and other liabilities

     107,799       100,140  

Deferred revenue

     110,286       113,270  
  

 

 

   

 

 

 

Total liabilities

     257,489       263,002  
  

 

 

   

 

 

 

Commitments and contingencies

    

Non-controlling interests

     7,578       1,353  
  

 

 

   

 

 

 

Shareholders’ equity

    

Capital stock common shares — no par value. Authorized — unlimited number. 62,747,512 issued and 62,521,916 outstanding (December 31, 2017 — 64,902,201 issued and 64,695,550 outstanding)

     431,003       445,797  

Less: Treasury stock, 225,596 shares at cost (December 31, 2017 — 206,651)

     (4,636     (5,133

Other equity

     179,767       175,300  

Accumulated deficit

     (75,908     (87,592

Accumulated other comprehensive loss

     (2,762     (626
  

 

 

   

 

 

 

Total shareholders’ equity attributable to common shareholders

     527,464       527,746  

Non-controlling interests

     76,981       74,511  
  

 

 

   

 

 

 

Total shareholders’ equity

     604,445       602,257  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 869,512     $ 866,612  
  

 

 

   

 

 

 

 

7


IMAX CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands of U.S. dollars)

(Unaudited)

 

     Six Months Ended
June 30,
 
     2018     2017  

Cash provided by (used in):

    

Operating Activities

    

Net income

   $ 22,322     $ 922  

Adjustments to reconcile net income to cash from operations:

    

Depreciation and amortization

     28,034       25,354  

Write-downs, net of recoveries

     1,686       13,155  

Change in deferred income taxes

     347       (3,133

Stock and other non-cash compensation

     11,920       12,570  

Unrealized foreign currency exchange gain

     473       (462

Loss from equity-accounted investments

     106       321  

Loss on non-cash contribution to equity-accounted investees

     199       198  

Investment in film assets

     (18,219     (19,589

Changes in other non-cash operating assets and liabilities

     (214     7,884  
  

 

 

   

 

 

 

Net cash provided by operating activities

     46,654       37,220  
  

 

 

   

 

 

 

Investing Activities

    

Purchase of property, plant and equipment

     (8,632     (9,771

Investment in joint revenue sharing equipment

     (8,455     (17,550

Acquisition of other intangible assets

     (1,705     (2,624

Investment in new business ventures

     —         (1,500
  

 

 

   

 

 

 

Net cash used in investing activities

     (18,792     (31,445
  

 

 

   

 

 

 

Financing Activities

    

Repayment of bank indebtedness

     (1,000     (1,000

Repurchase of common shares

     (46,452     (46,138

Treasury stock purchased for future settlement of restricted share units

     (4,636     (5,412

Taxes withheld and paid on employee stock awards vested

     (1,279     (187

Settlement of restricted share units and options

     (1,529     (14,048

Issuance of subsidiary shares to a non-controlling interest

     6,696       —    

Common shares issued – stock options exercised

     799       14,419  

Credit facility amendment fees paid

     (1,963     —    

Dividends paid to non-controlling interests

     (4,623     —    
  

 

 

   

 

 

 

Net cash used in financing activities

     (53,987     (52,366
  

 

 

   

 

 

 

Effects of exchange rate changes on cash

     442       76  
  

 

 

   

 

 

 

Decrease in cash and cash equivalents during period

     (25,683     (46,515

Cash and cash equivalents, beginning of period

     158,725       204,759  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 133,042     $ 158,244  
  

 

 

   

 

 

 

 

8


IMAX CORPORATION

SELECTED FINANCIAL DATA

In accordance with United States Generally Accepted Accounting Principles

(in thousands of U.S. dollars)

The Company has four primary reporting groups identified by nature of product sold or service provided: (1) Network Business, representing variable revenue generated by box-office results and which includes the reportable segments of IMAX DMR and contingent rent from the JRSAs and IMAX systems segments; (2) Theater Business, representing revenue generated by the sale and installation of theater systems and maintenance services, primarily related to the IMAX Systems and Theater System Maintenance reportable segments, and also includes fixed hybrid revenues and upfront installation costs from the JRSA segment; (3) New Business, which includes content licensing and distribution fees associated with our original content investments, virtual reality initiatives, IMAX Home Entertainment, and other business initiatives that are in the development and/or start-up phase, and (4) Other; which includes the film post-production and distribution segments and certain IMAX theaters that the Company owns and operates, camera rentals and other miscellaneous items.

 

     Three Months Ended
June 30,
    Six Months Ended
June 30,
 
     2018     2017     2018     2017  

Revenue

        

Network Business

        

IMAX DMR

   $ 36,161     $ 27,757     $ 63,214     $ 51,166  

Joint revenue sharing arrangements – contingent rent

     24,730       18,896       42,593       34,130  

IMAX systems – contingent rent

     —         790       —         1,478  
  

 

 

   

 

 

   

 

 

   

 

 

 
     60,891       47,443       105,807       86,774  
  

 

 

   

 

 

   

 

 

   

 

 

 

Theater Business

        

IMAX systems

        

Sales and sales-type leases

     11,981       16,125       30,118       23,067  

Ongoing fees and finance income

     3,282       2,613       6,012       5,198  

Joint revenue sharing arrangements – fixed fees

     1,022       1,408       1,022       1,878  

Theater system maintenance

     12,335       10,904       25,047       21,949  

Other theater

     2,255       1,699       3,631       3,864  
  

 

 

   

 

 

   

 

 

   

 

 

 
     30,875       32,749       65,830       55,956  
  

 

 

   

 

 

   

 

 

   

 

 

 

New Business

     3,116       1,311       3,723       2,591  
  

 

 

   

 

 

   

 

 

   

 

 

 

Other

        

Film distribution and post-production

     2,360       5,087       6,094       8,670  

Other

     1,103       1,168       1,875       2,423  
  

 

 

   

 

 

   

 

 

   

 

 

 
     3,463       6,255       7,969       11,093  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $ 98,345     $ 87,758     $ 183,329     $ 156,414  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin

        

Network Business

        

IMAX DMR(1)

   $ 24,280     $ 16,998     $ 43,063     $ 34,466  

Joint revenue sharing arrangements – contingent rent(1)

     18,621       13,668       31,362       23,920  

IMAX systems – contingent rent

     —         790       —         1,478  
  

 

 

   

 

 

   

 

 

   

 

 

 
     42,901       31,456       74,425       59,864  
  

 

 

   

 

 

   

 

 

   

 

 

 

Theater Business

        

IMAX systems

        

Sales and sales-type leases

     6,899       9,724       18,508       12,944  

Ongoing fees and finance income

     3,234       2,539       5,917       5,060  

Joint revenue sharing arrangements – fixed fees(1)

     246       176       246       264  

Theater system maintenance

     5,088       4,434       11,292       8,683  

Other theater

     563       405       517       834  
  

 

 

   

 

 

   

 

 

   

 

 

 
     16,030       17,278       36,480       27,785  
  

 

 

   

 

 

   

 

 

   

 

 

 

New Business

     1,906       (1,183     436       (1,520
  

 

 

   

 

 

   

 

 

   

 

 

 

Other

        

Film distribution and post-production(1)

     (387     1,998       59       (665

Other

     (46     (90     (304     (234
  

 

 

   

 

 

   

 

 

   

 

 

 
     (433     1,908       (245     (899
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $ 60,404     $ 49,459     $ 111,096     $ 85,230  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

9


 

(1) IMAX DMR segment margins include marketing costs of $6.5 million and $10.6 million for the three and six months ended June 30, 2018, respectively (2017 – $4.7 million and $7.3 million, respectively). Joint revenue sharing arrangements segment margins include advertising, marketing and commission costs of $1.0 million and $1.2 million for the three and six months ended June 30, 2018, respectively (2017 – $0.8 million and $1.2, respectively). IMAX system sales and sales-type lease segment margins include marketing and commission costs of $0.5 million and $1.2 million for the three and six months ended June 30, 2018, respectively (2017 – $0.8 million and $1.1 million). Film distribution and post production segment margins include marketing expense of $0.8 million and $2.0 million for the three and six months ended June 30, 2018 (2017 – recovery of $0.6 million and $0.7 million, respectively).

IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Non-GAAP Financial Measures:

In this release, the Company presents adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share, EBITDA and adjusted EBITDA as supplemental measures of performance of the Company, which are not recognized under U.S. GAAP. The Company presents adjusted net income and adjusted net income per diluted share because it believes that they are important supplemental measures of its comparable controllable operating performance and it wants to ensure that its investors fully understand the impact of its stock-based compensation (net of any related tax impact) on net income. In addition, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share because it believes that they are important supplemental measures of its comparable financial results and could potentially distort the analysis of trends in business performance and it wants to ensure that its investors fully understand the impact of net income attributable to non-controlling interests and its stock-based compensation (net of any related tax impact) in determining net income attributable to common shareholders. Management uses these measures to review operating performance on a comparable basis from period to period. However, these non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share should be considered in addition to, and not as a substitute for, net income and net income attributable to common shareholders and other measures of financial performance reported in accordance with U.S. GAAP.

Management uses “EBITDA”, as such term is defined in the Company’s credit agreement (and which is referred to herein as “Adjusted EBITDA per Credit Facility”, as the credit agreement includes additional adjustments beyond interest, taxes, depreciation and amortization). Adjusted EBITDA per Credit Facility (each as defined below) should not be construed as substitutes for net income or as better measures of liquidity as determined in accordance with U.S. GAAP. The Company believes that Adjusted EBITDA per Credit Facility is relevant and useful information widely used by analysts, investors and other interested parties in the Company’s industry.

 

     For the
3 months ended
June 30, 2018
    For the
12 months ended
June 30, 2018 (1)
 
(In thousands of U.S. Dollars)             

Net income

   $ 10,255     $ 33,918  

Add (subtract):

    

Provision for income taxes

     3,635       25,002  

Interest expense, net of interest income

     608       1,388  

Depreciation and amortization, including film asset amortization

     14,513       69,488  
  

 

 

   

 

 

 

EBITDA

   $ 29,011     $ 129,796  

Stock and other non-cash compensation

     6,779       23,141  

Write-downs, net of recoveries including asset impairments and receivable provisions

     650       18,099  

Exit costs, restructuring charges and associated impairments

     456       7,074  

Legal arbitration award

     7,500       7,500  

Loss from equity accounted investments

     100       489  
  

 

 

   

 

 

 

Adjusted EBITDA before non-controlling interests(2)

   $ 44,496     $ 186,099  

Adjusted EBITDA attributable to non-controlling interests

     (5,014     (24,404
  

 

 

   

 

 

 

Adjusted EBITDA per Credit Facility

   $ 39,482   $ 161,695
  

 

 

   

 

 

 

Adjusted EBITDA per Credit Facility, excluding impact from “Marvel’s Inhumans”

   $ 39,489   $ 148,930
  

 

 

   

 

 

 

Adjusted revenues attributable to common shareholders (3)

   $ 90,860     $ 367,281  
  

 

 

   

 

 

 

Adjusted EBITDA margin, excluding impact from “Marvel’s Inhumans”

     43.5     40.5
  

 

 

   

 

 

 

 

10


 

* Adjusted EBITDA per Credit Facility of $39.5 million and $161.7 million for the three and twelve months ended June 30, 2018 respectively, include the impact of the Company’s investment in “Marvel’s Inhumans”, which resulted in a less than $0.1 million and $12.2 million loss, respectively. However, as permitted by the Credit Facility, this loss was offset by addbacks of $nil and $13.3 million for amortization and by addbacks of, $nil and $11.7 million for impairment charges relating to the investment, in each case for the three and twelve months ended June 30, 2018, respectively. The net effect of these addbacks was to increase Adjusted EBITDA per Credit Facility by less than $0.1 million and $12.8 million for the three and twelve months ended June 30, 2018, respectively. This investment represents the Company’s first foray into a commercial television property, and therefore the Adjusted EBITDA per Credit Facility.
(1) Ratio of funded debt calculated using twelve months ended Adjusted EBITDA per Credit Facility.
(2) The Adjusted EBITDA per Credit Facility calculation specified for purpose of the minimum Adjusted EBITDA covenant excludes the reduction in Adjusted EBITDA from the Company’s non-controlling interests.
(3)         3 months ended
June 30, 2018
    12 months ended
June 30, 2018
 
   Total revenues      $ 98,345       $ 407,681  
   Greater China revenues    $ 23,341       $ 126,389    
   Non-controlling interest ownership percentage(4)      32.07       31.96  
     

 

 

     

 

 

   
   Deduction for non-controlling interest share of revenues        (7,485       (40,400
       

 

 

     

 

 

 
   Adjusted revenues attributable to common shareholders      $ 90,860       $ 367,281  
       

 

 

     

 

 

 
(4) Weighted average ownership percentage for change in non-controlling interest share

 

11


IMAX CORPORATION

OTHER INFORMATION

(in thousands of U.S. dollars)

Adjusted Net Income and Adjusted Diluted Per Share Calculations – Quarter Ended June 30, 2018 vs. 2017:

The Company reported net income of $10.3 million, which calculates to $0.16 per basic and diluted share, for the second quarter of 2018 as compared to a net income of $1.8 million, $0.03 per basic and diluted share for the second quarter of 2017.

Net income for the second quarter of 2018 includes a $6.8 million charge, or $0.10 per diluted share (2017 — $6.8 million or $0.10 per diluted share), for stock-based compensation and a $0.5 million charge, or $0.01 per diluted share for exit costs, restructuring charges and associated impairments (2017 — $10.3 million or $0.15 per diluted share), and a $7.5 million charge, or $0.12 per diluted share, for a legal arbitration award related to one of the Company’s litigation matters from 2006 (2017 — $nil or $nil per diluted share).

Adjusted net income, which consists of net income excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award and the related tax impact, was $21.7 million, or $0.34 per diluted share, for the second quarter of 2018 as compared to adjusted net income of $13.5 million, or $0.20 per diluted share, for the second quarter of 2017.

The Company reported net income attributable to common shareholders of $7.6 million, or $0.12 per basic and diluted share for the second quarter of 2018 (2017 — loss of $1.7 million or $0.03 per basic and diluted share).

Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award and the related tax impact, was $19.0 million, or $0.30 per diluted share, for the second quarter of 2018 as compared to adjusted net income attributable to common shareholders of $9.6 million, or $0.15 per diluted share, for the second quarter of 2017.

A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:

 

     Quarter Ended June 30,  
  

 

 

 
(In thousands of U.S. dollars, except per share amounts)    2018     2017  
     Net Income     Diluted EPS     Net Income     Diluted EPS  

Reported net income

   $ 10,255     $ 0.16     $ 1,809     $ 0.03  

Adjustments:

        

Stock-based compensation

     6,756       0.10       6,793       0.10  

Exit costs, restructuring charges and associated impairments

     456       0.01       10,258       0.15  

Legal arbitration award

     7,500       0.12       —         —    

Tax impact on items listed above

     (3,228     (0.05     (5,382     (0.08
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net income

     21,739       0.34       13,478       0.20  

Net (income) loss attributable to non-controlling interests

     (2,630     (0.04     (3,521     (0.05

Stock-based compensation (net of tax of less than $0.1 million and less than $0.1 million, respectively)

     (147     —         (153     —    

Exit costs, restructuring charges and associated impairments (net of tax of less than $0.1 million)

     —         —         (168     —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net income attributable to common shareholders

   $ 18,962     $ 0.30     $ 9,636     $ 0.15  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average diluted shares outstanding

       63,426         65,992  
    

 

 

     

 

 

 

 

12


Adjusted Net Income and Adjusted Diluted Per Share Calculations – Six Months Ended June 30, 2018 vs. 2017:

The Company reported net income of $22.3 million, or $0.35 per basic and diluted share, for the six months ended June 30, 2018 as compared to net income of $0.9 million, or $0.01 per basic and diluted share for the six months ended June 30, 2017.

Net income for the six months ended June 30, 2018 includes a $11.6 million charge, or $0.18 per diluted share (2017 — $12.1 million or $0.18 per diluted share) for stock-based compensation, and a $1.2 million charge, or $0.02 per diluted share for exit costs, restructuring charges and associated impairments (2017 — $10.3 million, or $0.15 per diluted share), and a $7.5 million charge, or $0.12 per diluted share for a legal arbitration award related to one of the Company’s litigation matters from 2006 (2017 — $nil or $nil per diluted share).

Adjusted net income, which consists of net income excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award and the related tax impact, was $38.8 million, or $0.61 per diluted share, for the six months ended June 30, 2018 as compared to adjusted net income of $16.5 million, or $0.24 per diluted share, for the six months ended June 30, 2017.

The Company reported a net income attributable to common shareholders of $16.1 million, or $0.25 per basic and diluted share for the six months ended June 30, 2018 (2017 — net loss of $1.6 million, or a loss of $0.02 per basic and diluted share).

Adjusted net income attributable to common shareholders, which consists of net income attributable to common shareholders excluding the impact of stock-based compensation, exit costs, restructuring charges and associated impairments, the legal arbitration award and the related tax impact, was $32.4 million, or $0.51 per diluted share, for the six months ended June 30, 2018 as compared to adjusted net income attributable to common shareholders of $13.5 million, or $0.20 per diluted share, for the six months ended June 30, 2017.

A reconciliation of net income and net income attributable to common shareholders, the most directly comparable U.S. GAAP measure, to adjusted net income, adjusted net income per diluted share, adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below:

 

     Six Months Ended June 30,  
  

 

 

 
(In thousands of U.S. dollars, except per share amounts)    2018     2017  
     Net Income     Diluted EPS     Net Income     Diluted EPS  

Reported net income

   $ 22,322     $ 0.35     $ 922     $ 0.01  

Adjustments:

        

Stock-based compensation

     11,603       0.18       12,057       0.18  

Exit costs, restructuring charges and associated impairments

     1,158       0.02       10,258       0.15  

Legal arbitration award

     7,500       0.12       —         —    

Tax impact on items listed above

     (3,787     (0.06     (6,723     (0.10
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net income

     38,796       0.61       16,514       0.24  

Net (income) loss attributable to non-controlling interests

     (6,192     (0.10     (2,559     (0.04

Stock-based compensation (net of tax of $0.1 million and $0.1 million, respectively)

     (204     —         (281     —    

Exit costs, restructuring charges and associated impairments (net of tax of less than $0.1 million)

     —         —         (168     —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net income attributable to common shareholders

   $ 32,400     $ 0.51     $ 13,506     $ 0.20  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average diluted shares outstanding

       64,006         66,548  
    

 

 

     

 

 

 

 

13


Free Cash Flow:

Free cash flow is defined as cash provided by operating activities minus cash used in investing activities (from the consolidated statements of cash flows). Cash provided by operating activities consist of net income, plus depreciation and amortization, plus the change in deferred income taxes, plus other non-cash items, plus changes in working capital, less investment in film assets, plus other changes in operating assets and liabilities. Cash used in investing activities includes capital expenditures, acquisitions and other cash used in investing activities. Management views free cash flow, a non-GAAP measure, as a measure of the Company’s after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented in the table below:

 

     For the
Three months ended
June 30, 2018
    For the
Six months ended
June 30, 2018
 
(In thousands of U.S. Dollars)             

Net cash provided by operating activities

   $ 31,191     $ 46,654  

Net cash used in investing activities

     (6,839     (18,792
  

 

 

   

 

 

 

Net cash flow

   $ 24,352     $ 27,862  
  

 

 

   

 

 

 

 

14